| Q47324534 | Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding. |
| Q33369021 | Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII. |
| Q33373076 | Diminished response to recombinant factor VIIa in a patient with idiopathic thrombocytopenic purpura |
| Q47650521 | Effect of a Rapidly Degrading Presolidified 10 kDa Chitosan/Blood Implant and Subchondral Marrow Stimulation Surgical Approach on Cartilage Resurfacing in a Sheep Model |
| Q33360978 | Immediate haemostasis with recombinant factor VIIa for haemorrhage following Hickman line insertion in acute myeloid leukaemia |
| Q33392610 | Long-term management of chronic immune thrombocytopenic purpura in adults |
| Q33372113 | Management of patients with refractory immune thrombocytopenic purpura |
| Q33342552 | On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation |
| Q80215773 | Postoperative pulmonary thromboembolism possibly associated with recombinant activated factor VII infusion for the treatment of uncontrolled hemorrhage during vertebral instrumentation |
| Q33366023 | Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment |
| Q33365354 | Recombinant activated factor VII in patients at high risk of bleeding |
| Q33363658 | Recombinant factor VIIa |
| Q36077574 | Recombinant factor VIIa in the treatment of non-hemophiliac bleeding |
| Q33365066 | Recombinant factor VIIa is an effective therapy for abdominal surgery and severe thrombocytopenia: a case report |
| Q33348111 | Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits |
| Q36412132 | Recombinant factor VIIa: a review on its clinical use. |
| Q36800526 | Recombinant-activated coagulation factor VIIa (NovoSeven): current development |
| Q33427920 | The Effects of Exogenous Administration of Human Coagulation Factors Following Pig-to-Baboon Liver Xenotransplantation |
| Q36784987 | The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review |
| Q35760073 | The potential use of recombinant activated factor VII in trauma and surgery |
| Q37416007 | The use of recombinant activated factor VII in platelet disorders: a critical review of the literature |
| Q37183517 | The use of recombinant activated factor VII in platelet-associated bleeding |
| Q33382014 | Understanding the therapeutic action of recombinant factor VIIa in platelet disorders |